Respiratory Research is an Open Access, peer-reviewed, online journal that considers manuscripts on all aspects of respiratory function and disease.

The journal welcomes studies on asthma, chronic obstructive pulmonary disease, cystic fibrosis, genetics, infectious diseases, interstitial lung diseases, lung development, lung tumors, occupational and environmental factors, pulmonary circulation, pulmonary pharmacology and therapeutics, respiratory critical care, respiratory immunology, respira ...

AstraZeneca PLC discovers, develops, manufactures, and markets prescription pharmaceuticals in the areas of cardiovascular, gastrointestinal, neuroscience, oncology, respiratory and inflammation, and infection worldwide. Its products include Arimidex for hormonal breast cancer; Crestor that provides treatment for managing cholesterol levels; Nexium for acid-related diseases; Seroquel, an atypical anti-psychotic therapy for treating schizophrenia and bipolar mania; and Symbicort for the maintenan ...

The history of AstraZeneca goes back nearly 100 years. In that time we’ve produced medications for cancer, heart disease, mental illness, stomach, infections and respiratory conditions, and our commitment to research grows stronger every year.

Today, not only are we working to discover the next new medicine, but we’re also working to help make healthcare a more meaningful, more personal experience for patients. The key to this goal is empowerment. By empowering patients with information, and ...

Apria Healthcare Group, Inc. and its subsidiaries provide home healthcare services and related support services in the United States. It operates in three segments: Home Respiratory Therapy, Home Infusion Therapy, and Home Medical Equipment. The Home Respiratory Therapy segment provides oxygen systems, stationary and portable ventilators, obstructive sleep apnea equipment, nebulizers, respiratory medications, and related clinical/administrative support. It serves patients with chronic obstructiv ...

Scientific excellence that achieves new standards of care drives the company's work. Over 20 products are currently in clinical development addressing a variety of key medical needs.

In addition to Biogen Idec's promising portfolio of drug candidates, the company's capabilities and capacity for protein manufacturing are world-class in quality and scale. The company is one of a handful of biotechnology companies that has three licensed and dedicated biological bulk-manufacturing facilities, in ...